Browse Articles

Discover research articles across all indexed journals

Effects of a self-determination theory-based smoking cessation intervention plus instant messaging via instant messaging for smokers with cancer: A randomized controlled trial.

Journal of Clinical Oncology Ho Cheung William Li, Herbert Ho Fung Loong, Joyce Oi Kwan Chung et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.314

314 Background: Continued smoking after a cancer diagnosis is associated with increased all-cause mortality and reduced treatment efficacy, yet many patients persist in smoking. This study evaluated the effectiveness of a self-determination theory–based smoking cessation intervention, supplemented with instant messaging, in helping smokers with cancer quit smoking. Methods: We conducted an assessor-blinded, multicenter randomized controlled trial involving 1,448 smokers with cancer attending outpatient clinics across five major acute care hospitals in Hong Kong. Participants in the intervention group received brief advice (5–8 minutes) from research nurses and selected their preferred quit schedule (immediate or progressive). For the first 6 months, they received smoking cessation advice via instant messaging weekly for 3 months and then monthly, plus four educational videos; those choosing progressive quitting also received a smoking reduction leaflet. Control participants received brief advice recommending immediate cessation, along with instant messaging containing general health advice on the same schedule. The primary outcome was biochemically validated smoking abstinence at 6 months, confirmed by both saliva cotinine and expired-air carbon monoxide levels. Results: Participants (N = 1448) included 1316 men (90.9%); the mean (SD) age at baseline was 63.0 (10.8) years. Among participants who self-reported abstinence at 6 months, 21.9% (69 of 315) had biochemical validation by both an exhaled carbon monoxide test and a saliva cotinine test. Compared with the control group, the intervention group had statistically higher biochemically validated abstinence at 6 months: 6.2% (45 of 724) vs 3.3% (24 of 724) ( P = 0.01), with an adjusted relative risk of 1.94 (95% CI, 1.50-2.51; P < 0.001). The intervention group also had higher self-reported quit rates at 6 months (26.2% [190 of 724] vs 17.3% [125 of 724], P < 0.001), with adjusted RR of 1.50 (95% CI, 1.32-1.70; P < 0.001). Conclusions: This brief, low-cost intervention grounded in self-determination theory significantly improved biochemically validated quit rates among smokers with cancer in outpatient settings. If implemented routinely, it could represent a scalable, cost-effective approach to promote smoking cessation in this high-risk population. Clinical trial information: NCT05643469 .

Efficacy of dance-based interventions on psychosocial outcomes and fatigue in breast cancer survivors: A systematic review and meta-analysis.

Journal of Clinical Oncology Melisha Koirala, Aakash Pandit Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.52

52 Background: Breast cancer survivors endure treatment side effects including cancer-related fatigue (CRF), sleep disturbances, and depression, impacting health status. Dance-based interventions, combining physical activity, social connection, and creative expression, may mitigate these effects. This study evaluated the efficacy of dance interventions versus standard care on quality of life (QoL) and symptom clusters in breast cancer patients to improve care. Methods: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted. Eligible studies investigated dance interventions (e.g., belly dance, tango, aerobic dance) delivered in-person or remotely for breast cancer patients undergoing active treatment or in survivorship. The primary outcomes were QoL, CRF, depressive symptoms, and sleep quality. Data were pooled using a random-effects model with inverse variance weighting. Effect sizes were calculated as Standardized Mean Differences (SMD) with 95% Confidence Intervals (CI). Heterogeneity was assessed using the I 2 statistic. Results: Five RCTs (N=455) were included in the final analysis. Dance interventions resulted in a statistically significant improvement in global Quality of Life (SMD 0.43; 95% CI 0.15–0.72; P=0.003), with low heterogeneity (I 2 =23%). A significant reduction in Cancer-Related Fatigue was observed in the intervention groups (SMD -0.50; 95% CI -0.81 to -0.18; P=0.002; I 2 =23%). Depressive symptoms were also significantly reduced (SMD -0.62; 95% CI -1.21 to -0.03; P=0.04), though heterogeneity was substantial (I 2 =69%). No significant improvement was found for sleep quality (P=0.67), which exhibited high heterogeneity (I 2 =88%) across the included studies. Conclusions: Dance-based interventions demonstrate efficacy in significantly improving quality of life and reducing fatigue and depressive symptoms among breast cancer survivors. These findings advocate for the inclusion of diverse dance modalities as viable, non-pharmacological supportive care options. Future multi-center trials are warranted to further investigate the impact on sleep quality and standardize intervention protocols. Pooled analysis of dance-based interventions on patient outcomes. Outcome Studies (N) SMD [95% CI] P-Value I 2 Quality of Life 3 0.43 [0.15, 0.72] 0.003 23% Fatigue (CRF) 3 -0.50 [-0.81, -0.18] 0.002 23% Depressive Symptoms 3 -0.62 [-1.21, -0.03] 0.04 69% Sleep Quality 2 -0.24 [-1.34, 0.86] 0.67 88% SMD: Standardized Mean Difference; CI: Confidence Interval; I 2 : Heterogeneity.

SPECTRAL: An Intelligent and Ultra‐Sensitive Photonic Hydrogel Platform for Biomarker‐Based Cancer Prediction

Angewandte Chemie International Edition Junjie Qin, Xingxing Yang, Jia Guo et al. Jul 01, 2026 DOI: 10.1002/anie.7454058

ABSTRACT Point‐of‐care (POC) biosensing holds great promise for noninvasive cancer diagnostics, as circulating tumor DNA (ctDNA) serves as a minimally invasive biomarker for early detection. However, effective ctDNA detection remains challenging due to low abundance and complex workflows. Herein, we present SPECTRAL (Smart Photonic‐hydrogel Enhanced chip for Cancer Type Recognition and AnaLysis), a sequencing‐free platform integrating photonic‐crystal hydrogels with charge‐neutral peptide nucleic acid (PNA) probes for efficient volumetric signal transduction and single‐nucleotide discrimination. Photonic‐crystal‐enhanced fluorescence amplifies signals of fluorescently labeled recombinase polymerase amplification (RPA) amplicons, achieving a detection limit of 100 copies per µL, with substantially improved sensitivity over conventional fluorescence assays. A single SPECTRAL chip simultaneously profiles 205 ctDNA mutations and eight protein biomarkers from plasma samples. The PNA sensor library is generated via an automated synthesis system guided by machine learning (ML)‐predicted probe difficulty. Multimodal signals are analyzed using cloud‐based ML to classify multiple cancer types (lung, breast, and colorectal), achieving 90.0% specificity and 86.7% sensitivity (87.5% overall accuracy) within 100 min from sample to diagnosis, based on validation with patient plasma samples. By combining molecular biosensing, photonic signal amplification, and AI‐driven analysis, SPECTRAL provides a low‐instrument‐dependent platform for decentralized liquid‐biopsy cancer diagnostics.

Insights from the competition–palatability trade-off paradigm on the reversibility of coral-to-macroalgae regime shifts

Scientific Reports Dana T. Cook, Sally J. Holbrook, Russell J. Schmitt Jul 01, 2026 DOI: 10.1038/s41598-026-59166-7

Abstract Regime shifts often have profoundly negative ramifications, underscoring the need to better understand processes that influence their reversibility. We explored the interplay between trophic and competitive interactions in shaping resilience of seaweed states following coral-to-macroalgae shifts on tropical reefs. Herbivore feeding and competition assays indicated that interactions involving common seaweed species were consistent with the competition-palatability trade-off paradigm: the most consumed alga ( Amansia rhodantha ) ranked as best competitor, the least consumed ( Turbinaria ornata ) ranked as the worst, and a third ( Sargassum pacificum ) was intermediate in both aspects. A two-year experiment revealed that mixed-species seaweed assemblages became overgrown by Amansia when herbivores were excluded, whereas Turbinaria was the only seaweed that persisted under high herbivory. Additional experimentation showed that much less herbivory was needed to extirpate palatable seaweeds relative to unpalatable Turbinaria . This relationship between seaweed resistance and palatability supports predications that coral-seaweed bistability becomes more likely when algae are less vulnerable to consumers. As such, the trade-off paradigm provided valuable insight into the nature and reversibility of coral-to-macroalgae shifts. Because such trade-offs are likely to be common in plant communities, these insights may well be applicable to regime shifts in a broad range of ecosystems.

Unlocking High Dielectric Tunability and Exceptional Electrocaloric Performance via Growth‐Driven Domain Dynamics

Advanced Materials Garima Kaura, Naveen Goyal, Fang Liu et al. Jul 01, 2026 DOI: 10.1002/adma.73824

ABSTRACT Achieving simultaneously high dielectric tunability, thermal and frequency stability, and efficient electrocaloric performance remains a major unresolved challenge in lead‐free ferroelectric films. These constraints limit the practical deployment of environmentally benign tunable components and solid‐state refrigeration technologies. To address this gap, we investigate Ba 0 . 7 Ca 0 . 3 TiO 3 thin films grown at 630, 670, and 700°C, establishing quantitative growth–structure–property correlations that enable co‐optimization of these functionalities. By integrating dielectric spectroscopy, Rayleigh analysis, phase‐field simulations, and electrocaloric measurements, we disentangle intrinsic and extrinsic contributions governing dielectric and electrocaloric behaviour. Film grown at 630°C exhibit the highest tunability (∼90%), dominated by extrinsic mechanisms with mixture of a/c nano‐domains, whereas film grown at 670°C yields a stable tunability (∼85%), low dielectric loss (<0.05), high cumulative quality factor ( CQF ∼1.6 × 10 4 ), and excellent thermal (300–420 K) and frequency (10 kHz–1 MHz) stability. In contrast, films grown at 700°C display the best performance of electrocaloric coefficient (ξ ∼0.025 K cm kV − 1 ), refrigerant capacity ( RC of ∼1900 J kg − 1 ) and an outstanding relative cooling power (RCP ≈ 1755 K 2 ), among the highest reported for lead‐free films. These results establish growth temperature as an effective control parameter for overcoming tunability–stability trade‐offs in adaptive microelectronics and solid‐state refrigeration.

Real-world insights of patterns of palliative and end-of-life care in patients with advanced cancer: LMIC single-center wake-up call.

Journal of Clinical Oncology Hafsa Thabassum, Krishna Chaitanya Puligundla, Radhika Parimkayala et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.336

336 Background: Early integration of palliative care (PC) is recommended in advanced cancer to improve quality of life and reduce aggressive end-of-life (EOL) care. However, these patterns are poorly characterised in real-world settings and are critical targets for quality improvement. Methods: We conducted a retrospective analysis of 250 patients with advanced solid tumors who died at a single tertiary care center between 2024 and 2025. Data extracted included demographics, cancer type, last chemotherapy timing, ICU and ward admissions in the last month of life, PC referral timing, place of death, and EOL care (EOLC) provision. Descriptive statistics were performed. Results: Median age was 53 years (range 21–85), 59% female. Common malignancies included lung (29%), breast (23%), and gastrointestinal cancers (25%). Chemotherapy was administered within one month of death in 57% of patients and within two weeks in 27%. ICU admission in the last month occurred in 81% of patients, and 69% died in the ICU. PC referral done in 66% of cases. Late referrals in 31% of patients hindering proper PC services. EOLC was provided to only 24% of patients; family hesitancy and late presentation were frequent barriers. Conclusions: In this cohort, advanced cancer patients frequently received aggressive care near death, with high rates of late chemotherapy, ICU utilization, and in-ICU deaths. Despite most patients being referred to PC, referrals were often delayed and EOLC was markedly underutilized. These findings highlight a critical gap in the systematic interventions, namely early integration of palliative principles and a potential over-reliance on intensive care at the EOL. Implications: Oncology programs should implement routine PC referral at advanced cancer diagnosis, develop protocols for appropriate ICU admission in terminal illness, and enhance clinician communication training to address family barriers and focus on patient-centered EOL goals and improve the quality of life in advanced cancer.

Causal machine learning–guided personalized immunochemotherapy strategies in intrahepatic cholangiocarcinoma (CMICC).

Journal of Clinical Oncology Jun-Hao Mei, Jian Lu, Kai Zhang et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.1

1 Background: Immunochemotherapy (IO-chemo) has become the first-line standard care for patients with advanced intrahepatic cholangiocarcinoma (iCCA), but the incremental benefit of adding IO varies greatly among individuals, making it urgent to develop systems for identifying high-benefit populations based on individualized treatment effect (ITE) estimation. Methods: This multi-cohort study included patients with iCCA who underwent either IO-chemo or chemo. The discovery cohort (2018–2022) included patients from three centers, while an independent cohort (2017–2023) from seven other centers served for external validation. Target trial emulation was employed to obtain unbiased average treatment effect estimation. We developed a causal machine-learning (ML) model (CMICC) to estimate heterogeneous treatment effects for IO-chemo. Based on predicted ITE, patients were stratified into high-benefit, no-to-moderate-benefit, and negative-benefit groups for each treatment. Counterfactual analyses compared overall survival between model-guided treatment selection and treatment actually received. The Qini and TOC curves were used to evaluate model performance. Model interpretability was assessed using SHAP. Results: A total of 1485 patients, 696 in the IO-chemo group and 789 in the chemo group, were included in the discovery cohort; 562 patients, 246 in the IO-chemo group and 316 in the chemo group, were included in the external validation cohort. Using a recursive feature addition approach, we selected 17 of 55 multidimensional variables to build the CMICC model in the discovery cohort. In the high-benefit group, compared with chemo, the hazard ratio (HR) for IO-chemo was 0.39 (95% CI, 0.30, 0.52), P <0.001, with mortality rates reduced by 24.1%, 31.2%, and 28.5% at 12, 24, and 36 months, respectively. In the no-to-moderate-benefit groups, IO–chemo did not significantly differ from chemotherapy (HR, 0.91; 95% CI, 0.70, 1.18; P =0.488). In the negative-benefit groups, IO–chemo was associated with worse outcomes than chemo (HR, 1.91; 95% CI, 1.47, 2.48; P <0.001), with 12-, 24-, and 36-month mortality increased by 29.9%, 11.0%, and 5.1%, respectively. Counterfactual analysis indicated that CMICC-guided treatment decisions could improve survival compared with actually received treatment (RecomIC-RecIC vs RecomIC-RecC: HR: 0.53 [95%CI, 0.43, 0.65], P <0.001; RecomC-RecC vs RecomC-RecIC: HR: 0.62 [95%CI, 0.50, 0.77], P <0.001). These results were independently confirmed in an external validation cohort. Conclusions: This study demonstrated that the causal ML-based CMICC model estimated ITE in iCCA patients receiving IO-chemo, performing effective benefit stratification, and may improve survival through individualized, CMICC-guided treatment decisions.

Engineering and supercritical systems for improving the solubility and nanoparticles by development of computational machine learning models

Scientific Reports Mashhour A. Alazwari, Nidal H. Abu-Hamdeh, Khalid H. Almitani Jul 01, 2026 DOI: 10.1038/s41598-026-60222-5

Scalable Production of Motion‐Enabled Self‐Charging Power Textiles with Highly Durable Zinc‐Ion Fiber Batteries

Advanced Materials Junbo Zhu, Jizhong Zhao, Jin He et al. Jul 01, 2026 DOI: 10.1002/adma.73836

ABSTRACT To meet the pressing need for convenient power in wearable electronics, this work presents self‐charging power textiles based on an integrated harvesting‐management‐storage strategy. The system employs fiber‐shaped triboelectric nanogenerators (F‐TENGs) paired with an energy management module to harvest energy from motion. Meanwhile, a Zn 2+ ‐assisted in situ rapid cross‐linking strategy using a sodium alginate/polyvinyl alcohol (SA/PVA) hydrogel electrolyte enables scalable production of fiber‐shaped zinc‐ion batteries (F‐ZIBs). This hydrogel electrolyte establishes continuous Zn 2+ conduction pathways, allowing the F‐ZIB to retain 95.7% capacity after 100 cycles at 0.2 A g −1 and 86.5% after 1,000 cycles at 2 A g −1 , with good environmental tolerance. The composite yarns for F‐TENGs are fully compatible with large‐scale manufacturing. By co‐weaving F‐ZIBs and F‐TENGs, the power textile demonstrates synergistic, long‐term operation capable of powering commercial devices such as smartphones, smart rings, and AI glasses. This study provides an accessible and universal energy solution for next‐generation self‐powered wearable systems.

Beating the clock: Immunotherapy timing, early immune modulation, and clinical outcomes in hepatocellular carcinoma.

Journal of Clinical Oncology Abhijith P.B., Akhil Santhosh, Narayanankutty Edavalath Warrier et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.322

322 Background: Circadian regulation of immune function is closely linked to hepatic physiology and may influence response to immune checkpoint inhibitors (ICIs). Whether the timing of ICI administration affects early systemic immune modulation and clinical outcomes in hepatocellular carcinoma (HCC) remains unclear. Methods: We conducted a prospective observational study of patients with advanced HCC treated with ICIs. Based on infusion records, treatment timing was categorized as morning (08:00–11:59) or non-morning (≥12:00) administration. Neutrophil–lymphocyte ratio (NLR) was assessed at baseline and prior to cycle 2. Early immune modulation was defined as a directional decrease in NLR. Associations between infusion timing and early NLR change were evaluated using Fisher’s exact test. Progression-free survival (PFS) was estimated using the Kaplan–Meier method and compared using the log-rank test. Results: A total of 42 patients were included; 24 (57%) received morning infusions and 18 (43%) received non-morning infusions. An early decrease in NLR was observed in 25 patients (60%). Early NLR decrease was more frequently observed among patients receiving morning ICI administration compared with non-morning administration (75% vs 39%; p = 0.027). Progression-free survival was significantly longer in patients demonstrating early NLR decrease (Group 1) compared with those without early NLR decrease (Group 2). Median PFS was 402 days (13.2 months; 95% CI 187–NR) in Group 1 versus 125 days (4.0 months; 95% CI 77–197) in Group 2. Kaplan–Meier analysis demonstrated a significant difference in PFS between the two groups (log-rank p = 0.00054). The 12-month PFS rate was 50.1% in Group 1 compared with 11.8% in Group 2. Conclusions: In this observational cohort of patients with hepatocellular carcinoma treated with immune checkpoint inhibitors, early favorable modulation of neutrophil–lymphocyte ratio was strongly associated with prolonged progression-free survival. Morning administration of immunotherapy was associated with a higher likelihood of early NLR decrease. These findings describe a clinically relevant association between immunotherapy timing, early immune biomarker dynamics, and outcomes, and support prospective evaluation of chronotherapy-informed immunotherapy strategies in HCC.

Diagnostic performance of the IOTA SR xCA-125 model in predicting ovarian malignancy in women undergoing surgery for adnexal masses.

Journal of Clinical Oncology Garima Yadav Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.205

205 Background: The preoperative differentiation of adnexal masses is crucial for appropriate patient management. While ultrasound is the primary imaging modality, standardized risk models are needed to improve accuracy and reduce operator dependency. The International Ovarian Tumor Analysis (IOTA) group has developed models like the Simple Rules Risk (SRR) assessment. This study aims to evaluate the diagnostic performance of the IOTA SRR model and a model combining the Simple Rules with serum CA-125, stratified by menopausal status (SRR-CA125). The primary objective was to study the diagnostic performance of the IOTA SRR-CA125 model in differentiating benign versus malignant/borderline ovarian neoplasms preoperatively in women undergoing surgery for adnexal masses. Methods: This was a prospective observational study conducted over a two-year period. The study included 139 women with an adnexal mass who were planned for surgery, excluding pregnant patients. A detailed history and clinical examination were performed, followed by standardized transvaginal and/or transabdominal ultrasonography. Serum CA-125 levels were analyzed for all patients. The malignancy risk for each adnexal mass was calculated using the IOTA SRR model and the stratified SRR-CA125 model. The final histopathological diagnosis was considered the gold standard. Results: The IOTA SRR model demonstrated excellent overall performance with an Area Under the ROC Curve (AUROC) of 0.953. At an optimal cutoff of ≥10.1%, it achieved a sensitivity of 94.4%, specificity of 83.5%, a Positive Predictive Value (PPV) of 66.7%, and a Negative Predictive Value (NPV) of 97.7%. The IOTA SRR-CA125 model showed distinct advantages when stratified: In pre-menopausal women, it yielded an AUROC of 0.936, with a sensitivity of 95.2% and a significantly improved specificity of 89.2%. In post-menopausal women, it yielded an AUROC of 0.907, with a lower sensitivity of 76.2% but an excellent specificity of 95.0%. Conclusions: Both the IOTA SRR and SRR-CA125 models are highly effective tools for the preoperative risk stratification of adnexal masses. The IOTA SRR model is an excellent, simple, and highly sensitive first-line test. The IOTA SRR-CA125 model provides a more nuanced assessment that significantly enhances specificity, making it valuable for reducing false-positive results. However, this benefit is coupled with a trade-off of lower sensitivity in post-menopausal women, highlighting the importance of selecting the appropriate model based on the clinical context and menopausal status.

The fascinating complexity of seagrass bio-fibres: insights from bio-chemo-hygro mechanical analysis for their reuse as soil reinforcement

Scientific Reports Jafar Karimiazar, Enrique Romero, Rossella Petti et al. Jul 01, 2026 DOI: 10.1038/s41598-026-59425-7

Abstract Beached Posidonia oceanica seagrass fibres are an abundant yet underutilised Mediterranean biowaste with potential for sustainable reinforcement of cement-treated sediments. We present a first multiscale bio–chemo–hygro–mechanical characterisation, combining high-resolution synchrotron X-ray tomography with a 250 nm voxel size, FE-SEM/EDX, tensile testing, water-retention measurements. An image-based method links Aegagropile diameter to fibre length, enabling targeted selection of fibres in the 10–25 mm range to minimise clustering and favour reinforcing-network formation within the potentially-treated material. Air-dried fibres exhibit higher tensile strength, whereas pre-soaked fibres show greater porosity, tortuosity, ductility and toughness, and water-retention capacity, highlighting a moisture-dependent trade-off between strength and deformability. Water-retention curves reveal two storage domains: intra-fibre absorption within the lumen’s porosity and capillarity in the inter-fibre pore space of bundled fibres. Within a cement-treated sediment mixture, 1% fibre addition does not significantly increase the unconfined compression strength, which is mainly governed by curing and cementation, but improves post-peak response, residual resistance, distributed cracking, ductility, and damage tolerance while maintaining comparable internal compactness. Ultrasonic pulse velocity results support that fibre inclusion does not compromise the internal compactness of the cement-treated sediment, while curing promotes progressive matrix densification. This dual mechanical and moisture-storage functionality positions Posidonia oceanica fibres as a circular bio-based reinforcement for cement-treated sediments.

Ion Permeation in Zwitterionic Hydrogel for Stable Solar Desalination and Power Generation

Advanced Materials Hongqi Zou, Xiangtong Meng, Jun Qi et al. Jul 01, 2026 DOI: 10.1002/adma.73816

ABSTRACT Interfacial solar evaporation holds promise for desalination but suffers from salt accumulation and unutilized salinity‐gradient energy. Conventional salt‐rejection strategies largely rely on passive diffusion, which is frequently compromised under high salinity. Here, we propose an ion permeation strategy using a zwitterionic hydrogel evaporator. The charge‐balanced hydrogel network enables downward ion permeation while suppressing upward water convection, thereby preventing interfacial crystallization. As a proof‐of‐concept, a zwitterionic hydrogel evaporator featuring spatially separated channels for brine convection and ion permeation was engineered. It sustained high evaporation rates over 3.50 kg m −2 h −1 across 0–25 wt.% brines and showed no salt accumulation after 105 h of continuous desalination in 3.5 wt.% brine. Spectroscopy and simulations validated the ion permeation mechanism. Furthermore, the resulting salinity gradient was leveraged for power generation, delivering a record‐high power output of 24 W m −2 . This work presents a stable ion permeation‐regulated paradigm for synergistic brine resource and solar energy utilization.

Real-world comparison of cabozantinib versus regorafenib as second-line therapy for advanced hepatocellular carcinoma after first-line immune checkpoint inhibitors: A propensity score–matched analysis.

Journal of Clinical Oncology Shankar Biswas, Yashasvi Srivastava, Ayman Hamadttu Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.132

132 Background: Immune checkpoint inhibitor (ICI)–based regimens are the standard first-line therapy for advanced hepatocellular carcinoma (HCC). Upon progression, cabozantinib and regorafenib are commonly used, yet no head-to-head or real-world comparative data exist specifically in the post-ICI setting. Prior indirect comparisons were limited to post-sorafenib populations. We compared the real-world effectiveness and safety of cabozantinib versus regorafenib after first-line ICI. Methods: Using the TriNetX Global Collaborative Network (171 healthcare organizations), we identified adults with HCC (C22.0) who received first-line ICI (atezolizumab, durvalumab, or nivolumab) followed by cabozantinib (n=484) or regorafenib (n=360). Propensity score matching (1:1) balanced cohorts on age, sex, race/ethnicity, Charlson comorbidity components, liver-specific covariates (cirrhosis, portal hypertension, ascites, chronic hepatitis), and laboratories (albumin, bilirubin, INR, platelets, creatinine). The primary outcome was overall survival (OS). Safety endpoints included diarrhea, fatigue, thrombocytopenia, hepatotoxicity, GI bleeding, ascites worsening, hyponatremia, ED visits, and hospitalizations. Results: After matching, 216 patients remained per cohort with well-balanced characteristics (all standardized differences <0.11). Results are shown in Table 1. Conclusions: In this propensity score–matched real-world analysis, cabozantinib was associated with significantly longer OS than regorafenib in patients with advanced HCC progressing on first-line ICI. However, cabozantinib had higher rates of diarrhea, fatigue, and thrombocytopenia, while regorafenib had more ED visits. These findings provide the first real-world head-to-head evidence for these TKIs in the post-ICI setting and may inform treatment sequencing decisions. Outcome Cabozantinib Regorafenib HR or RR (95% CI) P value Median OS, days 458 290 HR 1.31 (1.01–1.69) 0.041 Diarrhea, % 19.7 10.3 RR 0.52 (0.29–0.93) 0.023 Fatigue, % 21.0 11.8 RR 0.56 (0.33–0.97) 0.034 Thrombocytopenia, % 18.0 8.2 RR 0.46 (0.25–0.85) 0.010 ED visits, % 22.3 34.7 RR 1.55 (1.00–2.41) 0.047 Hepatotoxicity, % 9.5 6.1 RR 0.65 (0.31–1.36) 0.247 GI bleeding, % 14.5 14.5 RR 1.00 (0.61–1.65) 1.000 Ascites worsening, % 29.3 22.5 RR 0.77 (0.52–1.13) 0.177 Hospitalizations, % 39.7 40.0 RR 1.01 (0.64–1.59) 0.976

Association of oncology education through virtual engagement with gender and geographic disparities: A global longitudinal analysis (2022–2025).

Journal of Clinical Oncology Yan Leyfman, Viviana Cortiana, Maduri Balasubramanian et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.325

325 Background: Persistent gender disparities in academic visibility and leadership continue to limit equity in global oncology. Traditional conference models often impose geographic and financial barriers that disproportionately affect women and professionals from low- and middle-income countries (LMICs). The expansion of virtual education platforms offers a scalable opportunity to democratize access and amplify diverse voices. This study evaluated longitudinal trends in gender representation, engagement, and regional inclusivity across an international virtual oncology education consortium from January 2022 through December 2025. Methods: A retrospective longitudinal analysis was conducted on all keynote and spotlight sessions hosted between January 2022 and December 2025. Speaker demographics—including gender, specialty, academic affiliation, and geographic origin—were collected from institutional and publicly available records. Engagement metrics were obtained from multi-platform analytics (Twitter/X, LinkedIn, and YouTube) and analyzed using Symplur network analysis to assess dissemination reach, cross-disciplinary engagement, and geographic spread. Temporal trends in gender parity and LMIC representation were evaluated using descriptive statistics. Results: Over the four-year period, the program hosted more than 120 international oncology speakers across 150 sessions. Female representation increased from 38% in 2022 to 51% by 2024, achieving gender parity. Representation of women from LMICs rose from 12% to 28%, with notable increases from South Asia, Latin America, and the Middle East. Improvements were most pronounced in hematologic malignancies (+24%) and leadership and education-focused panels (+30%). Cumulative engagement exceeded 100 million impressions and 740,000 participants spanning 100 countries, including 44 LMICs. Engagement metrics did not differ by speaker gender (median impressions: 1.2 million vs. 1.1 million; p = 0.42). Network analysis demonstrated equitable amplification of sessions featuring women across interdisciplinary and geographic boundaries. Conclusions: This four-year global analysis demonstrates that structured virtual oncology education can reduce gender and geographic disparities in academic representation. Low-cost, borderless dissemination models can promote inclusive leadership visibility and expand participation from underrepresented regions. Virtual academic networks may complement traditional conferences and serve as scalable mechanisms to advance equity, collaboration, and capacity building in global cancer care.

Compatible Dynamically Wetting Electrolyte–Electrode Interface Design for Solid‐State Lithium–Sulfur Batteries

Angewandte Chemie International Edition Wanyuan Jiang, Danhui Wang, Borui Li et al. Jul 01, 2026 DOI: 10.1002/anie.1261984

ABSTRACT Solid‐state lithium–sulfur batteries feature high energy density and stability, but their practical application is constrained by limited ion transport at the electrode/solid‐state electrolyte interfaces and safety concerns arising from Li dendrites. This study presents a solid polymer electrolyte (SPSLL) constructed from an ultrathin flame‐retardant sulfonated copolymer (phthalazinone biphenylether sulfone) skeleton, into which a mixed phase of poly(vinylidene fluoride‐co‐hexafluoropropylene), succinonitrile, and lithium bis(trifluoromethanesulfonyl)imide is incorporated, together with a liquid metal interfacial wetting phase. This design enables a dynamic wetting mechanism that facilitates the formation of compatible electrolyte‐electrode interfaces. Through its sulfonated polymer skeleton, SPSLL promotes lithium salt dissociation and enhances thermal stability. Simultaneously, the LM serves as dynamic active sites, both strengthening interfacial physical contact and facilitating the formation of alloyed solid electrolyte interphases. As a result, the SPSLL‐based solid‐state Li‐sulfurized polyacrylonitrile (Li||SPAN) battery exhibits excellent cycling stability, maintaining a capacity retention of 92.2% and a Coulombic efficiency of 99.9% after 500 cycles. Furthermore, the SPSLL single‐layer pouch cell has an initial specific capacity of 948 mAh g −1 . The dynamic wetting strategy presented in this work offers a promising research direction for interface design in solid‐state batteries.

Investigating the separation and sorting of high-quality sperm in spiral microchannels using the Dean flow regime

Scientific Reports Saeed Derakhshan, Ataallah Kamyabi, Sareh Ashourzadeh et al. Jul 01, 2026 DOI: 10.1038/s41598-026-60619-2

Abstract Infertility is a growing global issue that affects millions of couples, posing significant challenges to personal and societal well-being. This study explores a novel approach to separating and sorting high-quality sperm using spiral microchannels to enhance assisted reproductive technologies (ART). We developed a spiral microchannel that utilizes inertial microfluidics and Dean flow to effectively separate sperm based on motility and morphology. The microchannel was fabricated using CO 2 laser engraving, resulting in a spiral design with a width of 0.35 mm, a total radius of 18.5 mm, and a depth of 0.2 mm. In a series of experiments, semen samples were injected at varying flow rates (ranging from 0.5 to 2 ml/min) to determine the optimal conditions for separating motile sperm from non-motile sperm. The results indicated that increasing the flow rates significantly improved separation efficiency. The formation of Dean’s vortices directed motile sperm toward the inner wall of the channel, while immotile sperm and solid particles were directed toward the inner wall. Notably, at a flow rate of 1.3 ml/min, the separation rate improved significantly, demonstrating the effectiveness of this microfluidic approach in yielding a higher quantity of viable sperm with less DNA damage while preserving sperm integrity as quantified by the Sperm Retrieval Index (SRI) with up to 4.5 fold improvement over baselines per World Health Organization standards. This innovative method holds promise as a valuable supplement to conventional ART techniques, offering scalability and reduced processing time. Sperm DNA fragmentation assays at select rates (0.5, 1.3, and 2 mL/min) confirmed the channel’s superiority in minimizing damage relative to raw samples, likely attributable to diminished reactive oxygen species exposure. This label-free, scalable method serves as an efficacious adjunct to traditional ART protocols, curtailing processing duration and oxidative stress while enhancing clinical applicability for routine infertility management.

Simultaneous Ultrahigh Energy Density and High Efficiency Achieved in Dipole‐Glass Polyimide Dielectrics

Advanced Materials Song Ding, Zihe Wang, Yiwei Wang et al. Jul 01, 2026 DOI: 10.1002/adma.73808

ABSTRACT Polymer‐based film capacitors are crucial components for modern electronic devices and advanced pulse power systems, but their performance is fundamentally constrained by the long‐standing trade‐off between high energy density and high charge–discharge efficiency. Here, a dipole‐glass polymer design is introduced, in which the active dipolar side groups are incorporated into a rigid polyimide backbone through flexible spacers. The rigid polyimide backbone provides a wide bandgap and a glassy matrix that suppresses leakage current and enables an ultrahigh breakdown strength of 964 MV m −1 , while the active acetyl side groups deliver easy and reversible orientational polarization with minimal steric hindrance. As a result, the optimized DGPI‐Ac film achieves a record‐high discharged energy density of 15.3 J cm −3 with a charge–discharge efficiency higher than 95% at room temperature, and it also shows excellent high‐temperature capacitive performance up to 200°C. This work establishes rational side‐chain engineering as an effective strategy, thereby unlocking the inherent energy storage potential of polymer dielectrics and advancing high‐power electrostatic energy storage technologies.

Upfront 69-gene next-generation sequencing versus reflex PCR in BCR::ABL1-negative myeloproliferative neoplasms: Diagnostic yield, prognostic impact, and cost analysis in an Indian cohort.

Journal of Clinical Oncology Moin Makda, Shrinidhi Nathany, Hrithik Bagga et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.163

163 Background: Sequential PCR testing for JAK2, CALR, and MPL mutations remains standard in MPN evaluation but misses non-canonical drivers and high-molecular-risk (HMR) mutations that inform MIPSS70+ v2.0 and GIPSS prognostic scoring. No Indian study has quantified the combined clinical and economic impact of upfront NGS. Methods: We analyzed 195 consecutive patients with suspected BCR::ABL1-negative MPNs at an Indian tertiary referral center. All underwent 69-gene targeted NGS (Oncomine Myeloid GX v2, Genexus platform). Quality control excluded variants with VAF <2%, VUS with VAF <5%, and non-MPN genes. Prognostic reclassification was assessed by MIPSS70+ v2.0 and GIPSS. A Markov model compared reflex-PCR-then-NGS versus NGS-first strategies using real-world laboratory costs (PCR ₹3,500–5,000/assay; 69-gene NGS ₹18,000/panel). Results: Median age was 47 years (range 10–86); 66% male. Canonical drivers were identified in 86 patients (44.1%): JAK2 V617F in 70 (35.9%), CALR in 14 (7.2%), MPL in 1 (0.5%), JAK2 exon 12 in 1 (0.5%). Among 109 triple-negative patients, NGS detected non-canonical mutations in 41 (21.0% of cohort). HMR mutations (ASXL1, SRSF2, EZH2, IDH1/2) were present in 21 (10.8%); 11 (52%) were PCR-invisible. Applying MIPSS70+ v2.0 and GIPSS, 32 patients (16.4%) were reclassified to higher risk categories based solely on NGS-detected mutations, directly informing transplant eligibility. Specifically, standard PCR algorithms missed crucial HMR mutations co-occurring with canonical drivers in 10 patients, resulting in artificially underestimated MIPSS70+ risk scores prior to NGS. The most frequent cooperating genes were TET2 (11.7%), SRSF2 (6.6%), and ASXL1 (4.1%). Fifty-nine patients (30.3%) harbored two or more co-occurring mutations. Notably, canonical driver mutations exhibited significantly higher variant allele frequencies compared to non-canonical cooperating mutations (mean 46.3% vs. 27.3%, p<0.001). The NGS-first strategy was economically dominant (Table). Conclusions: Upfront NGS detected actionable mutations in 65.1% of patients, reclassified 16.4% to higher MIPSS70+ v2.0/GIPSS risk, and was both cheaper and faster than reflex PCR workflows. These data support NGS as first-line diagnostic standard for MPN evaluation in resource-conscious settings. Outcome NGS-First Reflex-then-NGS Canonical drivers detected, n (%) 86 (44.1) 86 (44.1) Non-canonical mutations detected, n (%) 41 (21.0) 0 (0) HMR mutations detected, n (%) 21 (10.8) 10 (5.1) Prognostic reclassification, n (%) 32 (16.4) 0 (0) Mean cost per patient (₹) 18,000 21,633 Mean turnaround time (days) 3.0 6.6 Cost saving per patient (₹) 3,633 Reference

Divergence between expected and observed national cancer mortality after the COVID-19 pandemic: A population-based analysis.

Journal of Clinical Oncology Mohammad Soomro, Hala Soomro Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.303

303 Background: The COVID-19 pandemic disrupted cancer screening, diagnosis, and treatment, yet its long-term impact on cancer mortality remains uncertain. Aggregate mortality trends continued to decline during the pandemic, potentially obscuring site-specific deviations from historical trajectories. We evaluated whether individual malignancies diverged from expected mortality patterns following the pandemic. Methods: We conducted a national analysis using U.S. Multiple Cause of Death data (2003–2023), restricted to malignant neoplasms (ICD-10 C00–C97), representing >10 million deaths. Age-standardized mortality rates (ASMRs) were calculated. Expected rates for 2020–2023 were projected from pre-pandemic trends (2003–2019) using log-linear regression. Excess mortality was defined as percent deviation between observed and expected rates, with uncertainty estimated via parametric bootstrap and false discovery rate correction. Results: Overall cancer mortality largely followed projected trends. However, counterfactual analysis revealed significant site-level divergence. Hodgkin lymphoma demonstrated increased mortality (+9.5%, 95% CI 2.7–17.2), and historically stable prostate cancer mortality rose (+7.9%, 95% CI 2.8–13.2), with additional site-level increases and decreases observed. Divergence signals strengthened over time, peaking in 2022. In contrast, several malignancies exhibited below-expected mortality, consistent with potential diagnostic, coding, or competing-risk effects during periods of health-system strain. Conclusions: Aggregate cancer mortality trends mask meaningful disease-specific consequences of pandemic disruption. Divergent increases in malignancies such as Hodgkin lymphoma and prostate cancer may represent early signals of delayed diagnosis or treatment disruption. These findings highlight the need for targeted surveillance strategies to address post-pandemic cancer mortality shifts. Top site-level divergence from expected cancer mortality (2020–2023). Cancer site Excess mortality (%) 95% CI Direction Other & ill-defined sites +15.2 6.0–24.8 ↑ Hodgkin lymphoma +9.5 2.7–17.2 ↑ Malignant neoplasm without specification of site +8.5 4.3–12.8 ↑ Prostate +7.9 2.8–13.2 ↑ Bladder −6.3 −9.7 to −3.9 ↓ Mature T/NK-cell lymphomas −14.0 −19.8 to −6.5 ↓ Liver & intrahepatic bile ducts −15.5 −19.5 to −11.3 ↓ Excess mortality represents percent deviation between observed and expected age-standardized mortality rates for 2020–2023, where expected rates were projected from pre-pandemic trends (2003–2019) using log-linear regression. Direction indicates whether observed mortality was above (↑) or below (↓) projected values. False discovery rate correction was applied across cancer sites.